Article
Biological E seeks DCGI's nod for phase-3 trial of Corbevax as booster dose for Covishield, Covaxin
Rating:
0.0
Views:
81
Likes:
1
Library:
1
Biological E has sought permission from DCGI to conduct the phase-3 clinical trial for its Covid-19 vaccine Corbevax as a single booster dose for those who have been fully vaccinated with Covishield or Covaxin.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value